Revascularization after Minimally Invasive Coronary Artery Bypass Grafting in 566 Patients: Is It a Problem?

J Thorac Cardiovasc Surg. 2024 Nov 25:S0022-5223(24)01093-6. doi: 10.1016/j.jtcvs.2024.11.020. Online ahead of print.

Abstract

Objectives: Minimally invasive coronary artery bypass grafting (MICS CABG) allows visualization and revascularization of all myocardial territories through a small anterolateral thoracotomy, with or without cardiopulmonary bypass. It is increasing in popularity as a safe and effective alternative to sternotomy CABG. In this study, we examine the correlates and long-term outcomes of repeat revascularization (RR) in MICS CABG patients.

Methods: We prospectively followed all patients on annual or semi-annual basis who had undergone MICS CABG surgery over a 17-year period at a single institution. Cumulative incidence of RR was calculated accounting for competing risk of mortality. Kaplan-Meier curves were compared with log-rank test for survival and freedom from cardiac death at 12-years for both groups. Multivariable Cox proportional hazard models were performed to identify variables associated with RR and its impact on long-term survival.

Results: Clinical follow-up was complete for 100% of patients (N=566) at a mean of 7.0±4.4 years. Forty-nine (8.7%) patients required RR after their MICS CABG, for a cumulative incidence at 12 years of 14.8 ± 2.5%. The most common indication was progression of native coronary disease in 23 (46.9% of RR) patients. Perioperative transfusion was the only variable associated with RR (HR 5.0; 95%CI: 2.4, 10.3). Comparing patients who had RR versus those who did not, there was no significant difference in late survival (92.1±4.5% vs. 80.3±3.0%; P=0.18).

Conclusions: Among 566 patients who underwent MICS CABG over a 17-year period, RR was an infrequent event affecting 8.7% of patients, with no negative impact on long-term survival.

Keywords: Minimally invasive; coronary artery bypass grafting; repeat revascularization.